Intravenous beta2agonists versus intravenous aminophylline for acute asthma

Source: Cochrane Area: Evidence > Drug Specific Reviews Background     Inhaled beta-agonist therapy is central to the management of acute asthma. This review evaluates the benefit of an additional use of intravenous beta2-agonist agents.     Objectives     To determine the benefit of adding intravenous (IV) beta2-agonists to inhaled beta2-agonist therapy for acute asthma treated in the emergency department.     Search methods     Randomised controlled trials (RCTs) were identified using the Cochrane Airways Group Register which is a compilation of systematic searches of MEDLINE, EMBASE, CINAHL, and CENTRAL as well as handsearching of 20 respiratory journals. Bibliographies from included studies and known reviews were also searched. Primary authors and content experts were contacted to identify eligible studies. The search was performed in September 2012.       Selection criteria   ...
Source: NeLM - Drug Specific Reviews - Category: Drugs & Pharmacology Source Type: news